ArticleAllergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology2024

Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational study.

Kenneth R Chapman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.